459 related articles for article (PubMed ID: 25545744)
1. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.
Henning SM; Wang P; Said JW; Huang M; Grogan T; Elashoff D; Carpenter CL; Heber D; Aronson WJ
Prostate; 2015 Apr; 75(5):550-9. PubMed ID: 25545744
[TBL] [Abstract][Full Text] [Related]
2. Re: Randomized Clinical Trial of Brewed Green and Black Tea in Men with Prostate Cancer Prior to Prostatectomy.
Taneja SS
J Urol; 2015 Sep; 194(3):704-5. PubMed ID: 26292860
[No Abstract] [Full Text] [Related]
3. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.
Wang P; Aronson WJ; Huang M; Zhang Y; Lee RP; Heber D; Henning SM
Cancer Prev Res (Phila); 2010 Aug; 3(8):985-93. PubMed ID: 20628004
[TBL] [Abstract][Full Text] [Related]
4. Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy.
Wang P; Henning SM; Magyar CE; Elshimali Y; Heber D; Vadgama JV
J Exp Clin Cancer Res; 2016 May; 35():73. PubMed ID: 27151407
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.
Freedland SJ; Carducci M; Kroeger N; Partin A; Rao JY; Jin Y; Kerkoutian S; Wu H; Li Y; Creel P; Mundy K; Gurganus R; Fedor H; King SA; Zhang Y; Heber D; Pantuck AJ
Cancer Prev Res (Phila); 2013 Oct; 6(10):1120-7. PubMed ID: 23985577
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive effects of tea in prostate cancer: green tea versus black tea.
Henning SM; Wang P; Heber D
Mol Nutr Food Res; 2011 Jun; 55(6):905-20. PubMed ID: 21538852
[TBL] [Abstract][Full Text] [Related]
7. Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.
Wang P; Vadgama JV; Said JW; Magyar CE; Doan N; Heber D; Henning SM
J Nutr Biochem; 2014 Jan; 25(1):73-80. PubMed ID: 24314868
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.
Nguyen MM; Ahmann FR; Nagle RB; Hsu CH; Tangrea JA; Parnes HL; Sokoloff MH; Gretzer MB; Chow HH
Cancer Prev Res (Phila); 2012 Feb; 5(2):290-8. PubMed ID: 22044694
[TBL] [Abstract][Full Text] [Related]
9. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption.
Henning SM; Aronson W; Niu Y; Conde F; Lee NH; Seeram NP; Lee RP; Lu J; Harris DM; Moro A; Hong J; Pak-Shan L; Barnard RJ; Ziaee HG; Csathy G; Go VL; Wang H; Heber D
J Nutr; 2006 Jul; 136(7):1839-43. PubMed ID: 16772446
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
Pantuck AJ; Leppert JT; Zomorodian N; Aronson W; Hong J; Barnard RJ; Seeram N; Liker H; Wang H; Elashoff R; Heber D; Aviram M; Ignarro L; Belldegrun A
Clin Cancer Res; 2006 Jul; 12(13):4018-26. PubMed ID: 16818701
[TBL] [Abstract][Full Text] [Related]
11. A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer.
van Die MD; Williams SG; Emery J; Bone KM; Taylor JM; Lusk E; Pirotta MV
Prostate; 2017 May; 77(7):765-775. PubMed ID: 28181675
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer.
Henning SM; Wang P; Lee RP; Trang A; Husari G; Yang J; Grojean EM; Ly A; Hsu M; Heber D; Grogan T; Li Z; Aronson WJ
Food Funct; 2020 May; 11(5):4114-4122. PubMed ID: 32347270
[TBL] [Abstract][Full Text] [Related]
13. Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis.
Henning SM; Wang P; Said J; Magyar C; Castor B; Doan N; Tosity C; Moro A; Gao K; Li L; Heber D
J Nutr Biochem; 2012 Nov; 23(11):1537-42. PubMed ID: 22405694
[TBL] [Abstract][Full Text] [Related]
14. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro.
McLarty J; Bigelow RL; Smith M; Elmajian D; Ankem M; Cardelli JA
Cancer Prev Res (Phila); 2009 Jul; 2(7):673-82. PubMed ID: 19542190
[TBL] [Abstract][Full Text] [Related]
15. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B
Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.
Jarred RA; Keikha M; Dowling C; McPherson SJ; Clare AM; Husband AJ; Pedersen JS; Frydenberg M; Risbridger GP
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1689-96. PubMed ID: 12496063
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of the human anti-epithelial cell adhesion molecule antibody adecatumumab in prostate cancer patients with increasing serum levels of prostate-specific antigen after radical prostatectomy.
Marschner N; Rüttinger D; Zugmaier G; Nemere G; Lehmann J; Obrist P; Baeuerle PA; Wolf A; Schmidt M; Abrahamsson PA; Reinhardt C; Heidenreich A
Urol Int; 2010; 85(4):386-95. PubMed ID: 20606402
[TBL] [Abstract][Full Text] [Related]
18. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.
Loeb S; Zhu X; Schroder FH; Roobol MJ
BJU Int; 2012 Dec; 110(11):1678-83. PubMed ID: 22998182
[TBL] [Abstract][Full Text] [Related]
19. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
[TBL] [Abstract][Full Text] [Related]
20. Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.
Gee J; Bailey H; Kim K; Kolesar J; Havighurst T; Tutsch KD; See W; Cohen MB; Street N; Levan L; Jarrard D; Wilding G
Prostate; 2013 Jun; 73(9):970-8. PubMed ID: 23335089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
